Top 5 Large-Cap Healthcare Stocks to Buy Now

Page 5 of 5

1. AbbVie Inc (NYSE:ABBV)

Topping the list is AbbVie Inc (NYSE:ABBV), which Rhenman owned 500,000 shares of on December 30, ranking it as the fund’s top stock pick supplanting mid-cap BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) atop its 13F portfolio.

The dividend aristocrat had a big Q4, growing revenue by 59% year-over-year to $13.9 billion. Autoimmune disorder treatment Humira was again AbbVie’s top seller pulling in $5.1 billion in sales. AbbVie has several other strong performers during the quarter, including Venclexta (sales up 46.2%) and Vraylar (sales up 38%). The 2023 exclusivity loss of Humira, which is projected to lead to a sales decline that year, could weigh over the stock in the near-term but AbbVie projects returning to solid high-single-digit growth in the second-half of the 2020’s.

If you’re in the mood for some potentially mouth-watering returns, don’t miss the list of the 10 Best Water Stocks and ETFs to Buy in 2021.

Please also see  12 Best Genomic Stocks To Buy Now and 10 Cheap Healthcare Stocks To Invest In.

Disclosure: None.

Page 5 of 5